Results 221 to 230 of about 142,129 (337)

Synthesis, characterization and drug loading properties of a medical metal-organic framework constructed from bioactive curcumin derivatives. [PDF]

PLoS One
Feng X, Liu L, Wang L, Li Y, Liu G.
europepmc   +1 more source

Rescue Therapy With Quad Zygoma After Failure of Full‐Arch Implant Rehabilitation: A Retrospective Study With a Mean Follow‐Up of 8 Years

Clinical Oral Implants Research, EarlyView.
ABSTRACT Objectives To evaluate the long‐term clinical outcomes of quad zygomatic implants (ZIs) as a rescue therapy for patients with failed full‐arch implant rehabilitation in the maxilla due to advanced peri‐implantitis. Material and Methods This was a retrospective cohort study of all patients treated with the Quad Zygoma Protocol. Primary outcomes
Shengchi Fan, Wenjie Zhou, Bilal Al‐Nawas, Eduard Valmaseda‐Castellón, Rubén Davó   +4 more
wiley   +1 more source

Kinetic Study of the Hydrolysis of synthesized Ibuprofen Ester and its Biological Activity

, 2013
Baghdad Science Journal
openalex   +2 more sources

Patent Ductus Arteriosus in Preterm Neonates: A 2025 Synthesis of Evidence-Based Paradigms and Emerging Clinical Strategies. [PDF]

Pediatr Discov
Bhatt AH, Nimbalkar SM, Patel DV, Pujara RK.   +3 more
europepmc   +1 more source

Influence of the lysosomal elastase inhibitor eglin on development of interstitial lung edema in E. coli bacteremia in pigs [PDF]

, 1987
Jochum, Marianne, Redl, H., Schlag, G., Siebeck, Matthias, Thetter, O., Welter, H. F.   +5 more
core  

Craving and Drug Reward: A Comparison of Celecoxib and Ibuprofen in Detoxifying Opiate Addicts.

, 2017
Sara Jafari, Sana Khajehpour, Emran Mohammad Razzaghi, Kazem Heidari, Mehdi Soleimani, Padideh Ghaeli   +5 more
openalex   +1 more source

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess the safety, tolerability, and treatment effects of rimegepant 75 mg every other calendar day (EOD) for the preventive treatment of migraine in a 52‐week, open‐label extension (OLE) study. Background Rimegepant is an oral small molecule calcitonin gene–related peptide receptor antagonist approved for the acute treatment of ...
David Kudrow, Robert S. Croop, Alexandra Thiry, Richard B. Lipton   +3 more
wiley   +1 more source

Erosive Potential of Pediatric Syrup Medications on the Human Enamel: Ex Vivo Study. [PDF]

Dent J (Basel)
Douiri FZ, Shayegan A.
europepmc   +1 more source

Reaction pattern of alveolar cells in the posttraumatic lung failure [PDF]

, 1987
Jochum, Marianne, Joka, T., Kreutzfelder, E., Oberste-Beulmann, S., Obertacke, U., Pison, V., Redl, H., Schlag, G., Schönfeld, W., Zilow, G.   +9 more
core  

Ibuprofen gargle for quality of life and pain improvement in oral lichen planus: randomized crossover and long-term extension phase II study

Yumi Kitahiro, Yasumasa Kakei, Takeshi Ioroi, Nanae Yatagai, Masahiko Kashin, Masaki Kobayashi, Asami Morioka, Kazuhiro Yamamoto, Takumi Hasegawa, Masaya Akashi, Ikuko Yano   +10 more
openalex   +1 more source